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Inhibition of glomerular cell apoptosis by heparin. property and is synthesized in various tissues, especially
Background. Heparin, the multifunctional glycosaminogly- in the liver, lung, and gut. In the kidney, it has been
can, has been considered a therapeutic agent for glomerular shown that glomerular epithelial and endothelial cellsdiseases. Although a number of biological properties are postu-
have the ability to produce heparin-like glycosaminogly-lated to explain its therapeutic utility, it is unknown whether
cans [1, 2].heparin affects cell survival in the glomerulus. In this report,
we investigated the effect of heparin on apoptosis of glomerular Heparin has been used as a therapeutic agent for the
cells. treatment of glomerulonephritis. Systemic administra-
Methods. Cultured rat mesangial cells were pretreated with tion of heparin attenuates several experimental and hu-
heparin or heparan sulfate proteoglycan (HSPG) and were
man glomerular diseases, including antiglomerular base-exposed to proapoptotic stimuli. To examine an effect of hepa-
ment membrane nephritis, Habu venom-induced injury,rin on spontaneous apoptosis that occurs in explanted glom-
eruli, isolated rat glomeruli were incubated in the presence puromycin aminonucleoside nephrosis, remnant-kidney
or absence of heparin. Apoptosis was evaluated by Hoechst models, anti-Thy 1 glomerulonephritis, and lupus nephri-
33258 staining, terminal deoxynucleotidyl transferase-medi- tis [3, 4]. The therapeutic action of heparin is ascribed
ated dUTP nick-end labeling, and agarose gel electrophoresis
to its anti-inflammatory properties, including inhibitionto detect DNA fragmentation. The effect of heparin on activa-
of blood coagulation, complement inactivation, and sup-tor protein 1 (AP-1), a crucial mediator for oxidant-induced
pression of leukocyte function [4]. For example, heparinapoptosis, was examined by Northern blot analysis and a re-
porter assay. inhibits leukocyte rolling and adhesion on the endothe-
Results. Heparin and HSPG inhibited apoptosis of mesan- lium [5, 6], and aggregation, degranulation and superox-
gial cells triggered by hydrogen peroxide. It was associated ide anion generation by activated neutrophils [7]. In ad-with blunted expression of c-fos/c-jun mRNAs and suppression
dition to these effects, heparin has direct actions onof AP-1 activation. The cytoprotective effect of heparin was
resident glomerular cells. Heparin and heparan sulfatealso observed in other cell types and in apoptosis triggered by
different stimuli. That is, (a) heparin inhibited mesangial cell proteoglycan (HSPG) inhibit mitogenesis and migration
apoptosis induced by staurosporine, pyrrolidine dithiocarba- of cultured mesangial cells [1, 2, 8–10]. Heparin and
mate, and ultraviolet light, and (b) heparin suppressed oxidant- HSPG inhibit induction of immediate early genes [11,induced apoptosis of NRK49F fibroblasts and Madin-Darby
12] and attenuate the expression of potentially injuriouscanine kidney epithelial cells. Furthermore, heparin attenuated
mediators in mesangial cells [13]. Heparin and HSPGspontaneous apoptosis of podocytes in explanted glomeruli.
Conclusions. These results indicate the novel potential of also inhibit proliferation of glomerular epithelial cells
heparin as an inhibitor of apoptosis in several cell types, includ- [14, 15] and protect endothelial cells from oxygen radical-
ing glomerular cells. mediated injury [16, 17].
Although a number of biological properties have been
postulated to explain the therapeutic effects of heparin
on glomerular disease, it is still unknown whether and
Heparin is generally described as an anionic polysac- how heparin modulates survival of glomerular cells. In
charide or a sulfated glycosaminoglycan with irregular this investigation, we address a novel potential of heparin
sequences. Heparin has a characteristic, anticoagulant for protecting glomerular cells and other cell types from
apoptosis, which is initiated by several different stimuli.
Key words: glomerulus, hydrogen peroxide, activator protein 1, apo-
ptosis inhibition, cell death, anti-inflammation.
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were identified as being of the mesangial cell phenotype Hoechst staining
as described before [18]. The kidney fibroblast cell line Cells were fixed with 4% formaldehyde in phosphate-
NRK49F and the tubular epithelial cell line Madin- buffered saline (PBS) for 10 minutes, stained by Hoechst
Darby canine kidney (MDCK) were purchased from 33258 (10 mg/ml; Sigma) for one hour, and subjected to
American Type Culture Collection (ATCC, Manassas, fluorescence microscopy. Apoptotic cells were identified
VA, USA). All cells were maintained in Dulbecco’s by nuclear condensation and/or fragmentation. Percent-
modified Eagle’s medium (DMEM)/Ham’s F-12 (GIB- ages of apoptotic cells were evaluated quantitatively.
CO BRL, Gaithersburg, MD, USA) supplemented with When a substantial number of cells were detaching, de-
100 U/ml of penicillin G, 100 mg/ml of streptomycin, tached cells and attached cells were evaluated separately,
0.25 mg/ml of amphotericin B, and 10% fetal calf serum and total percentages of apoptotic cells were calculated.
(FCS).
TUNELNormal glomeruli were isolated from adult male
TUNEL assay was performed using the Apoptosis De-Sprague-Dawley rats (250 to 300 g body wt) using the
tection System, Fluorescein (Promega, Madison, WI,conventional sieving method [19]. We recently reported
USA) [19]. In brief, cells and isolated glomeruli (5 3 103)that resident cells, especially podocytes, spontaneously
were fixed by 4% paraformaldehyde in PBS overnight atundergo apoptosis immediately after explantation of
48C. The samples were washed three times with PBS andnormal glomeruli [19]. For the induction of the spontane-
were permeabilized by 0.2% Triton X-100 in PBS for 15ous apoptosis, glomeruli were suspended in culture me-
minutes on ice. After washing twice, cells and glomerulidium containing 1% FCS, incubated at 378C for up to
were equilibrated at room temperature for 15 to 30 min-two hours in the presence or absence of heparin (0 to
utes in equilibration buffer (200 mm potassium cacodyl-100 U/ml; Sigma Immunochemicals, St. Louis, MO,
ate, 0.2 mm dithiothreitol, 0.25 mg/ml bovine serum albu-USA) and subjected to agarose gel electrophoresis and
min, and 2.5 mm cobalt chloride in 25 mm Tris-HCl,terminal deoxynucleotidyl transferase-mediated dUTP
pH 6.6) and then incubated in the presence of 5 mmnick-end labeling (TUNEL), as described later in this
fluorescein-12-dUTP, 10 mm dATP, 100 mm ethylenedi-article.
aminetetraacetic acid (EDTA), and terminal deoxy-
nucleotidyl transferase at 378C for 1.5 hours in dark. ThePharmacological manipulations
tailing reaction was terminated by 2 3 standard salineFor the induction of apoptosis, confluent mesangial
citrate (SSC). The samples were washed three times withcells cultured in the presence of 1% FCS for 24 hours
PBS and were analyzed by fluorescence microscopy.were treated by hydrogen peroxide (H2O2; 100 to 150 mm;
Sigma), staurosporine (1.5 mm; Sigma), or pyrrolidine Ladder detection assay
dithiocarbamate (PDTC; 50 mm; Sigma) for up to 24
After induction of apoptosis, cells (5 3 105/sample,
hours. Irradiation of ultraviolet light (200 mJ) was also
both attached and detached cells) and isolated glomeruli
used to induce apoptosis of mesangial cells. Compared (2.5 to 5 3 103) were lyzed with 150 ml hypotonic lysis
with mesangial cells and NRK49F cells, MDCK cells buffer (10 mm EDTA, 0.5% Triton X-100 in 10 mm Tris-
are relatively resistant to H2O2-induced injury. A higher HCl, pH 7.4) for 15 minutes on ice and were precipitated
concentration of H2O2 (350 mm) was used to induce apo- with 2.5% polyethylene glycol and 1 m NaCl for 15 min-
ptosis for this cell type. utes at 48C. After centrifugation at 16,000 g for 20 min-
To examine the effect of heparin and HSPG, cells utes at room temperature, the supernatant was incubated
were pretreated with heparin (5 to 100 U/ml; Sigma) or in the presence of proteinase K (300 mg/ml; Sigma) at
HSPG (500 mg/ml; Sigma) for 1.5 hours and were then 378C for one hour and precipitated with isopropanol at
exposed to proapoptotic stimuli. Heparin at the concen- 2208C. After centrifugation, each pellet was dissolved
tration of 100 U/ml was generally used for experiments. in 10 ml of Tris-EDTA (pH 7.6) and electrophoresed on
Heparin and HSPG were present in culture medium a 1.5% agarose gel containing ethidium bromide. Ladder
throughout exposure of the cells to apoptotic stimuli. formation of oligonucleosomal DNA was detected under
ultraviolet light.
Trypan blue analysis
Northern blot analysisViability of cells (both attached and detached cells)
was assessed by trypan blue exclusion. After induction Expression of c-fos and c-jun was examined by North-
of apoptosis, cells were gently trypsinized and mixed with ern blot analysis [20, 21]. In brief, mesangial cells were
the same volume of 0.4% trypan blue solution (Sigma). exposed to H2O2 (100 mm) for 0.5 to 2 hours in the
Percentages of viable cells were evaluated by light mi- presence or absence of heparin (5 to 100 U/ml) and were
subjected to analysis. Total RNA was extracted by acroscopy. Assays were performed in quadruplicate.
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Fig. 1. Effect of heparin on oxidant-triggered apoptosis of mesangial cells. Confluent rat mesangial cells were pretreated with (1) or without (2)
heparin (5 to 100 U/ml) for 1.5 hours in the presence of 1% fetal calf serum (FCS) and were exposed to hydrogen peroxide (H2O2; 100 to 150
mm) for up to 24 hours. Heparin 100 U/ml was generally used for experiments. (A) Phase-contrast microscopy: 150 mm H2O2 for 16 hours. (B)
Trypan blue analysis. After induction of apoptosis (100 mm H2O2, 24 hr), mesangial cells were gently trypsinized and mixed with the same volume
of trypan blue solution. Percentages of viable cells were evaluated by light microscopy. Assays were performed in quadruplicate. Data were
expressed as means 6 se. Asterisks indicate statistically significant differences (P , 0.05). (C) Trypan blue analysis: dose-dependent effect. Cells
were pretreated with 0 to 100 U/ml heparin, exposed to 150 mm H2O2 for 24 hours, and subjected to trypan blue analysis. (D) Hoechst staining.
After induction of apoptosis (150 mm H2O2, 24 hr), cells were fixed and stained by Hoechst 33258 for one hour and subjected to fluorescence
microscopy. Apoptotic cells were identified by nuclear condensation and/or fragmentation, and percentages of apoptotic cells were calculated.
Assays were performed in quadruplicate. An asterisk indicates a statistically significant difference against H2O2-treated, heparin-untreated cells
(P , 0.05). (E) Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL). After induction of apoptosis (150 mm H2O2,
6 hr), cells were subjected to TUNEL, as described in the Methods section (fluorescence microscopy). (F) Ladder detection assay. Cells were
pretreated with 0 to 100 U/ml heparin, exposed to 150 mm H2O2 for 16 hours, and subjected to agarose gel electrophoresis. (G) Effect of heparan
sulfate proteoglycan (HSPG). Mesangial cells were pretreated with (1) or without (2) HSPG (500 mg/ml) for 1.5 hours in the presence of 1%
FCS and exposed to H2O2 (150 mm) for 24 hours. Percentages of apoptotic cells were evaluated by Hoechst staining. An asterisk indicates a
statistically significant difference (P , 0.05).
single-step method, and RNA samples were electropho- ride, 60 mm sodium citrate), 5 3 Denhardt’s solution,
10% dextran sulfate, 50 mg/ml herring sperm DNA, andresed on 1.2% agarose gels and transferred onto nitrocel-
lulose membranes. For hybridization, a human c-fos 50 mg/ml poly(A), washed at 508C and exposed to Kodak
XAR films at 2808C.cDNA [22] and a human c-jun cDNA [23] were labeled
with 32P-dCTP using the random priming method. As a
Reporter assayloading control, expression of glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) was used. The mem- Activator protein 1 (AP-1) binds to the cis element,
12-O-tetradecanoate 13-acetate response element (TRE)branes were hybridized with probes at 658C overnight
in a solution containing 4 3 SSC (600 mm sodium chlo- and triggers transcription of target genes. To evaluate
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U-test to compare data in different groups. A P value
of ,0.05 was used to indicate a statistically significant
difference.
RESULTS
Effect of heparin on oxidant-triggered apoptosis of
mesangial cells
Mesangial cells undergo apoptosis following exposure
to H2O2 [27]. To examine the effect of heparin on the
oxidant-initiated apoptosis, mesangial cells were pre-
treated with or without heparin (100 U/ml) and were
exposed to H2O2 (150 mm). Microscopic analysis showed
that heparin protected mesangial cells from morphologi-
cal apoptotic changes induced by the oxidant stress
(Fig. 1A).
The apoptotic process is divided into three phases.
In the first and second phases, the function of cellular
membranes is retained intact, but in the third phase, cell
membranes are progressively degenerated. In this last
phase, secondary necrosis is observed as the final step
of apoptosis [28]. To confirm that heparin indeed inhibits
mesangial cell death, trypan blue analysis was performed.
Compared with untreated control (cell survival 98.4 6
0.2%, mean 6 se), H2O2 reduced the cell viability to
32.9 6 2.8%. Pretreatment with heparin significantly im-
proved the cell survival to 84.7 6 0.5% (P , 0.05; Fig.
1B). The cytoprotective effect of heparin was dose-
dependent. An obvious increase in the cell survival was
observed at a low concentration (5 U/ml), but its maxi-
mum effect was achieved by the highest concentration
tested (100 U/ml; Fig. 1C).Fig. 1. Continued
The suppressive effect of heparin on the mesangial
cell apoptosis was confirmed by Hoechst staining and
TUNEL. Staining of the cells with Hoechst 33258 exhib-
ited condensation and fragmentation of nuclei in H2O2-
the activity of AP-1 in mesangial cells, a reporter assay exposed cells. It was markedly suppressed by the treat-
was used [24]. In brief, mesangial cells were cultured in ment with heparin; that is, the percentage of apoptosis
24-well plates (1.0 to 1.2 3 105/well). Using a calcium- was reduced from 29.5 6 2.6% to 2.1 6 0.2% by the
phosphate coprecipitation method, the cells were trans- treatment with heparin (Fig. 1D). Similarly, the number
fected with a reporter plasmid pTRE-LacZ (0.3 to 0.4 mg/ of TUNEL-positive cells was dramatically decreased by
well) [25] that introduces a b-galactosidase gene (lacZ) externally added heparin (Fig. 1E).
under the control of TRE. After incubation for 48 hours The anti-apoptotic effect of heparin was further con-
in the presence of 1% FCS, the cells were pretreated firmed by ladder detection assay. Agarose gel electro-
with or without heparin for 1.5 hours and were stimulated phoresis exhibited DNA ladder formation in H2O2-ex-
by H2O2 (100 mm) for 24 hours. The cells were fixed and posed mesangial cells. The DNA laddering was
subjected to 5-bromo-4-chloro-3-indolyl b-D-galacto- abrogated by the treatment with heparin (Fig. 1F). The
pyranoside (X-gal) assay, as described previously [26]. lowest concentration (5 U/ml) of heparin was found to
Activity of AP-1 was evaluated by counting X-gal– be sufficient to suppress the oxidant-induced DNA frag-
positive cells in each well. Assays were performed in mentation.
quadruplicate. To examine whether other heparin-like species also
inhibit apoptosis of mesangial cells, the effect of HSPG
Statistical analysis was tested. Mesangial cells were pretreated with or with-
Data are expressed as means 6 se. Statistical analysis out HSPG (500 mg/ml) for 1.5 hours and were exposed
to H2O2 (150 mm). Hoechst staining showed that thewas performed using the nonparametric Mann–Whitney
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percentage of apoptotic cells was significantly reduced
by the treatment with HSPG [percentages of apoptosis
were 30.1 6 3.4% in HSPG (2), and 4.2 6 0.9% in
HSPG (1); Fig. 1G].
Effect of heparin on the activation of activator
protein 1, the mediator for oxidant-induced apoptosis
Activator protein 1 plays a crucial role in the H2O2-
triggered apoptosis in mesangial cells [27]. We found
that H2O2 induces expression of c-fos/c-jun and activation
of AP-1 [27]. Down-regulation of c-Jun/AP-1 using ei-
ther a dominant-negative mutant of c-jun, an antisense
c-jun, or a pharmacological inhibitor of c-jun attenuated
the H2O2-initiated apoptosis [27]. To elucidate mecha-
nisms involved in the anti-apoptotic action of heparin,
its effect on AP-1 was examined. Northern blot analysis
showed that H2O2 induced expression of c-fos and c-jun
in mesangial cells. Pretreatment with heparin abrogated
the induction of these genes (Fig. 2A). Low concentra-
tions (5 to 10 U/ml) of heparin were found to be sufficient
to suppress the expression of c-fos and c-jun (data not
shown). Consistently, transient transfection assay with a
TRE reporter plasmid showed that the activation of
AP-1 by H2O2 was abolished in the presence of heparin
(Fig. 2B).
Fig. 2. Effect of heparin on the H2O2-triggered activation of activator
protein 1 (AP-1). (A) Northern blot analysis. Mesangial cells wereEffects of heparin on apoptosis of mesangial cells in
exposed to H2O2 (100 mm) for 0.5 to 2 hours in the presence (1) orresponse to different stimuli
absence (2) of heparin (100 U/ml) and were subjected to Northern
blot analysis of c-fos and c-jun. As a loading control, expression ofTo examine whether the cytoprotective action of hepa-
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was shown onrin is restricted to apoptosis triggered by H2O2, other the bottom. (B) Reporter assay. Mesangial cells were transfected with
pro-apoptotic stimuli, including staurosporine and a reporter plasmid pTRE-LacZ that introduces a b-galactosidase gene
(lacZ) under the control of 12-O-tetradecanoate 13-acetate responsePDTC, were tested. Mesangial cells were pretreated with
element (TRE). After incubation for 48 hours in the presence of 1%or without heparin and were exposed to staurosporine
fetal calf serum (FCS), the cells were pretreated with (1) or without
(1.5 mm) or PDTC (50 mm) for 24 hours. Hoechst staining (2) heparin for 1.5 hours and stimulated by H2O2 (100 mm) for 24 hours.
The cells were fixed and subjected to 5-bromo-4-chloro-3-indolyl b-D-showed that heparin significantly attenuated apoptosis
galactopyranoside (X-gal) assay. Activity of AP-1 was evaluated byin both experimental settings (Fig. 3 A, B). That is, the
counting X-gal-positive cells in each well. Data are shown as a fold
percentages of apoptotic cells were reduced from 34.6 6 increase against the value of untreated control. Assays were performed
in quadruplicate. Asterisks indicate statistically significant differences1.0% [heparin (2)] to 6.9 6 0.2% [heparin (1)] in stauro-
(P , 0.05).sporine-treated cells and from 12.1 6 1.1% [heparin (2)]
to 1.9 6 0.2% [heparin (1)] in PDTC-treated cells.
The anti-apoptotic effect of heparin was further exam-
ined using ultraviolet light as a trigger. Mesangial cells
were pretreated with or without heparin and subjected to dependent effects of H2O2 on individual cell types were
initially examined to determine minimum concentrationsultraviolet irradiation (200 mJ). After 24 hours, Hoechst
staining was performed. As shown in Figure 3C, heparin required for cellular damage. Compared with mesangial
cells and NRK49F cells, MDCK cells were found to besignificantly attenuated the ultraviolet-induced apopto-
sis. The percentage of apoptotic cells was reduced from relatively resistant to H2O2-induced injury. The mini-
mum concentrations required were 150 mm for NRK49F17.0 6 1.6% [heparin (2)] to 6.9 6 0.9% [heparin (1)]
by the treatment with heparin. cells and 350 mm for MDCK cells (data not shown). Using
these concentrations, the effects of heparin on H2O2-
Effects of heparin on H2O2-initiated apoptosis in other induced apoptosis were examined.
cell types NRK49F fibroblasts exposed to H2O2 exhibited shrink-
age of the cytoplasm, membrane blebbing, and condensa-To examine whether the anti-apoptotic effect of hepa-
rin against H2O2 is specific to mesangial cells, NRK49F tion of nuclei, like in mesangial cells (data not shown).
Hoechst staining showed condensation and fragmenta-fibroblasts and MDCK epithelial cells were tested. Dose-
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Fig. 3. Effects of heparin on apoptosis of
mesangial cells triggered by different stimuli.
Confluent mesangial cells were pretreated
with (1) or without (2) heparin (100 U/ml)
for 1.5 hours in the presence of 1% FCS and
were exposed to (A) staurosporine (1.5 mm),
(B) pyrrolidine dithiocarbamate (PDTC, 50
mm), or (C) ultraviolet light (UV, 200 mJ) for
20 to 24 hours. Cells were fixed, stained by
Hoechst 33258, and subjected to fluorescence
microscopy. Assays were performed in qua-
druplicate. Asterisks indicate statistically sig-
nificant differences compared with the cells
exposed to apoptotic stimuli without heparin
(P , 0.05).
tion of nuclei in H2O2-exposed cells. Pretreatment with showed that heparin inhibited DNA fragmentation in
H2O2-exposed NRK49F cells and MDCK cells (Fig. 4C).heparin significantly suppressed the apoptotic change
(Fig. 4A). The percentage of apoptotic cells was reduced
Effect of heparin on spontaneous apoptosis infrom 22.0 6 1.4% [heparin (2)] to 1.1 6 0.4% [heparin
explanted glomeruli(1)]. Similarly, apoptosis of H2O2-exposed MDCK cells
was attenuated by the treatment with heparin (Fig. 4B). We recently found that glomerular cells, especially
The percentage of apoptotic cells was significantly re- podocytes, spontaneously undergo apoptosis immedi-
duced from 15.0 6 0.4% [heparin (2)] to 3.3 6 0.5% ately after explantation of isolated glomeruli [19]. A
number of resident cells are positive for TUNEL when[heparin (1)]. Consistently, agarose gel electrophoresis
Fig. 4. Effects of heparin on H2O2-initiated apoptosis in other cell
types. NRK49F fibroblasts and MDCK epithelial cells were pretreated
with (1) or without (2) heparin (100 U/ml) for 1.5 hours in the presence
of 1% FCS and were exposed to H2O2 (150 mm for NRK49F and 350
mm for MDCK) for 16 to 20 hours. Cells were then stained by Hoechst
33258 or subjected to ladder detection assay. Assays were performed
in quadruplicate. Asterisks indicate statistically significant differences
compared with H2O2-exposed, heparin-untreated cells (P , 0.05). (A)
Hoechst staining of NRK49F cells (fluorescence microscopy). (B)
Hoechst staining of detached MDCK cells. In contrast to mesangial
cells and NRK49F cells, the majority of apoptotic MDCK cells detached
from the culture plate. To evaluate apoptosis of MDCK cells quantita-
tively, detached cells and attached cells were stained by Hoechst 33258
separately, and total percentages of apoptotic MDCK cells were calcu-
lated. (C) Ladder-detection assay.
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examined at two hours after the explantation. Ladder
detection assay showed that within 15 minutes DNA
fragmentation was detectable. DNA laddering was
peaked at two hours and attenuated thereafter [19]. To
examine whether heparin inhibits the spontaneous apo-
ptosis of glomerular cells, isolated rat glomeruli were
incubated in the absence or presence of heparin (5 to
100 U/ml) for two hours. Agarose gel electrophoresis
revealed that heparin dose-dependently inhibited the
DNA fragmentation observed in explanted glomeruli
(Fig. 5A). Obvious inhibition was observed even at the
lowest concentration (5 U/ml), but the maximum effect
was achieved by higher concentrations (50 to 100 U/ml).
The effect of heparin on the spontaneous apoptosis
was further confirmed by TUNEL assay. After incuba-
tion of glomeruli for 20 minutes in the absence of hepa-
rin, the number of TUNEL-positive cells was dramati-
cally increased, as reported previously [19]. Treatment
with heparin markedly diminished the number of apo-
ptotic cells (Fig. 5B). The effect of heparin was further
tested using longer incubation periods. When examined
after incubation for 45 minutes and 2 hours, the sup-
pressive effect of heparin on glomerular cell apoptosis
was still observed. However, substantial numbers of glo-
merular cells became TUNEL positive even in the pres-
ence of 100 U/ml heparin (data not shown).
DISCUSSION
Heparin has been considered an anti-mitotic agent for
several cell types, especially for vascular smooth muscle
cells and glomerular mesangial cells [3, 29]. In contrast,
information is very limited regarding the effect of hepa-
rin on apoptotic processes. One previous report sug-
gested that heparin may facilitate apoptosis in human
peripheral blood neutrophils [30]. In our investigation,
we demonstrated a novel potential of heparin as an inhib-
itor of apoptosis in glomerular cells. This study showed
Fig. 5. Effect of heparin on spontaneous apoptosis in explanted glo-that heparin inhibits apoptosis in cultured mesangial cells meruli. (A) Ladder detection assay. Isolated, normal rat glomeruli were
and explanted glomeruli. incubated at 378C for two hours in culture medium containing 1% FCS
and 0 to 100 U/ml of heparin and subjected to agarose gel electrophore-Molecular mechanisms involved in the antiapoptotic
sis. (B) TUNEL assay. Isolated glomeruli were incubated at 378C for
action of heparin are largely unknown. However, as dem- 20 minutes in the presence (1) or absence (2) of heparin (100 U/ml)
and were subjected to TUNEL assay, as described in the Methodsonstrated in this report, heparin attenuated H2O2-trig-
section. Glomeruli were examined by fluorescence microscopy.gered expression of c-fos and c-jun. Reporter assays
showed that heparin diminished activation of AP-1 in
response to H2O2. These data suggested a possibility that
heparin inhibits apoptosis of mesangial cells via interven- result, together with our current findings, indicates a
tion in the AP-1 pathway, the crucial signaling cascade possibility that the inhibitory effect of heparin on the
involved in the oxidant-induced apoptosis [27]. The ac- AP-1 pathway may be mainly through reduction in the
tivity of AP-1 is regulated by both production of AP-1 mRNA and protein levels of AP-1 components.
protein and its activation via c-Jun N-terminal kinase The molecular targets for the anti-apoptotic action of
(JNK). We examined the effect of heparin on the activity heparin might be upstream of AP-1. Previous reports
of JNK using c-Jun as a substrate. Immunoblot analysis have shown that heparin facilitates the release of extra-
showed that heparin did not attenuate activation of JNK cellular superoxide dismutase from endothelial cells,
leading to their protection from oxygen radical-mediatedin response to H2O2 (our unpublished observation). This
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